Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

CRISPR Gene editing therapy is used for the first time in living humans with amazing results. Nick Saban has strong reaction ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

Researchers used CRISPR screening in tumor organoids and mice to identify two genes, Ctnna1 and Bcl2l13, that suppress ...

India's GenAI infrastructure is being built, but can a public-private partnership outpace the trillion-dollar budgets of US ...

Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...

The global pest control industry is steering towards a whopping $32.8 billion valuation by 2028, growing at a compound annual ...

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

A study identified two key genes (CTNNA1 and BCL2L13) as suppressors in spread of colorectal cancer, revealing new strategies ...

The company will begin filing to global regulators in the first half of 2026. Read more at straitstimes.com. Read more at ...